GCPII Inhibition Promotes Remyelination after Peripheral Nerve Injury in Aged Mice

Yu Su,Meixiang Huang,Ajit G. Thomas,John Maragakis,Kaitlyn D. J. Huizar,Yuxin Zheng,Ying Wu,Mohamed H. Farah,Barbara S. Slusher

DOI: https://doi.org/10.3390/ijms25136893

IF: 5.6

2024-06-24

International Journal of Molecular Sciences

Abstract:Peripheral nerve injuries (PNIs) represent a significant clinical challenge, particularly in elderly populations where axonal remyelination and regeneration are impaired. Developing therapies to enhance these processes is crucial for improving PNI repair outcomes. Glutamate carboxypeptidase II (GCPII) is a neuropeptidase that plays a pivotal role in modulating glutamate signaling through its enzymatic cleavage of the abundant neuropeptide N-acetyl aspartyl glutamate (NAAG) to liberate glutamate. Within the PNS, GCPII is expressed in Schwann cells and activated macrophages, and its expression is amplified with aging. In this study, we explored the therapeutic potential of inhibiting GCPII activity following PNI. We report significant GCPII protein and activity upregulation following PNI, which was normalized by the potent and selective GCPII inhibitor 2-(phosphonomethyl)-pentanedioic acid (2-PMPA). In vitro, 2-PMPA robustly enhanced myelination in dorsal root ganglion (DRG) explants. In vivo, using a sciatic nerve crush injury model in aged mice, 2-PMPA accelerated remyelination, as evidenced by increased myelin sheath thickness and higher numbers of remyelinated axons. These findings suggest that GCPII inhibition may be a promising therapeutic strategy to enhance remyelination and potentially improve functional recovery after PNI, which is especially relevant in elderly PNI patients where this process is compromised.

biochemistry & molecular biology,chemistry, multidisciplinary

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to promote remyelination by inhibiting glutamate carboxypeptidase II (GCPII) after peripheral nerve injury (PNI) in aged mice. Specifically, the research aims to: 1. **Explore the role of GCPII in PNI**: The study found that after peripheral nerve injury, the expression and activity of GCPII increased significantly, especially in Schwann cells and activated macrophages. This phenomenon is particularly evident in aged mice. 2. **Evaluate the effect of GCPII inhibitors**: Using the potent and selective GCPII inhibitor 2 - (phosphonomethyl) - glutaric acid (2 - PMPA), the research team evaluated its effect on remyelination in vitro and in vivo experiments. The results showed that 2 - PMPA can significantly enhance myelination and accelerate remyelination after peripheral nerve injury in aged mice. 3. **Improve the remyelination ability of aged individuals**: Since the remyelination ability of aged individuals is impaired, the study paid special attention to the effect of GCPII inhibitors in aged mice. The results indicate that 2 - PMPA can also effectively promote remyelination in aged mice, which provides new hope for the treatment of peripheral nerve injury in the elderly population. In summary, the main objective of this paper is to improve remyelination after peripheral nerve injury in aged mice by inhibiting GCPII, thereby enhancing the effect of nerve repair.

GCPII Inhibition Promotes Remyelination after Peripheral Nerve Injury in Aged Mice

P2Y2 Receptor Mediated Neuronal Regeneration and Angiogenesis to Affect Functional Recovery in Rats with Spinal Cord Injury

P2Y12 Receptor Mediates Apoptosis and Demyelination to Affect Functional Recovery in Mice with Spinal Cord Injury.

PMP2 regulates myelin thickening and ATP production during remyelination

Innate immune training restores pro-reparative myeloid functions to promote remyelination in the aged central nervous system

Mice Lacking Glutamate Carboxypeptidase II Develop Normally, but Are Less Susceptible to Traumatic Brain Injury

Suppression of Glutamate Carboxypeptidase II Ameliorates Neuronal Apoptosis from Ischemic Brain Injury

Inhibition of CRMP2 Phosphorylation Suppresses Microglia Activation in the Retina and Optic Nerve and Promotes Optic Nerve Regeneration After Optic Nerve Injury

Inhibition of Glutamate Carboxypeptidase II (GCPII) activity as a treatment for cognitive impairment in multiple sclerosis

Inhibition of Schwann Cell Pyroptosis Promotes Nerve Regeneration in Peripheral Nerve Injury in Rats

P2Y12-targeted modulation of microglial phenotypes: A novel therapeutic strategy for enhanced axonal regeneration post-spinal cord injury

Glutamate carboxypeptidase II gene knockout attenuates oxidative stress and cortical apoptosis after traumatic brain injury

Senescent-like microglia limit remyelination through the senescence associated secretory phenotype

Multimodal Enhancement of Remyelination by Exercise with a Pivotal Role for Oligodendroglial PGC1α

Niacin-mediated rejuvenation of macrophage/microglia enhances remyelination of the aging central nervous system

Multisite Injections of Canine Glial-Restricted Progenitors Promote Brain Myelination and Extend the Survival of Dysmyelinated Mice

Identification of key regulatory genes involved in myelination after spinal cord injury by GSEA analysis

Activation of P2X7R Inhibits Proliferation and Promotes the Migration and Differentiation of Schwann Cells

GSK3β inhibitor promotes myelination and mitigates muscle atrophy after peripheral nerve injury

The toll-like receptor 2 agonist Pam3CSK4 is neuroprotective after spinal cord injury

Inhibition of phospholipase D promotes neurological function recovery and reduces neuroinflammation after spinal cord injury in mice